In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
Coronavirus
Compuscript Ltd Feb 4 2025 Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic. Understanding the structural and functional interactions between the virus and host cells is critical for developing therapeutic strategies. In this study in silico docking models were employed to investigate
din zilele anterioare